热门资讯> 正文
Mangoceuticals报告第一季度业绩
2024-05-17 04:52
- Mangoceuticals press release (NASDAQ:MGRX): Q1 Revenue of $0.21M (+110.0% Y/Y).
More on Mangoceuticals
- Mangoceuticals acquires a global patent portfolio
- Mangoceuticals signs deal for initial development of erectile dysfunction products in Mexico
- Financial information for Mangoceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。